GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Suzhou Highfine Biotech Co Ltd (SZSE:301393) » Definitions » PB Ratio

Suzhou Highfine Biotech Co (SZSE:301393) PB Ratio : 1.80 (As of Sep. 25, 2024)


View and export this data going back to 2023. Start your Free Trial

What is Suzhou Highfine Biotech Co PB Ratio?

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. As of today (2024-09-25), Suzhou Highfine Biotech Co's share price is ¥37.10. Suzhou Highfine Biotech Co's Book Value per Share for the quarter that ended in Jun. 2024 was ¥20.56. Hence, Suzhou Highfine Biotech Co's PB Ratio of today is 1.80.

Good Sign:

Suzhou Highfine Biotech Co Ltd stock PB Ratio (=1.72) is close to 2-year low of 1.65

The historical rank and industry rank for Suzhou Highfine Biotech Co's PB Ratio or its related term are showing as below:

SZSE:301393' s PB Ratio Range Over the Past 10 Years
Min: 1.65   Med: 2.4   Max: 14.99
Current: 1.8

During the past 6 years, Suzhou Highfine Biotech Co's highest PB Ratio was 14.99. The lowest was 1.65. And the median was 2.40.

SZSE:301393's PB Ratio is ranked better than
53.17% of 946 companies
in the Drug Manufacturers industry
Industry Median: 1.9 vs SZSE:301393: 1.80

During the past 12 months, Suzhou Highfine Biotech Co's average Book Value Per Share Growth Rate was 207.20% per year. During the past 3 years, the average Book Value Per Share Growth Rate was 85.30% per year. During the past 5 years, the average Book Value Per Share Growth Rate was 38.40% per year.

During the past 6 years, the highest 3-Year average Book Value Per Share Growth Rate of Suzhou Highfine Biotech Co was 85.30% per year. The lowest was 3.20% per year. And the median was 40.60% per year.

Back to Basics: PB Ratio


Suzhou Highfine Biotech Co PB Ratio Historical Data

The historical data trend for Suzhou Highfine Biotech Co's PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Suzhou Highfine Biotech Co PB Ratio Chart

Suzhou Highfine Biotech Co Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
PB Ratio
Get a 7-Day Free Trial - - - - 2.93

Suzhou Highfine Biotech Co Quarterly Data
Dec18 Dec19 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24
PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - 3.68 2.93 2.15 2.07

Competitive Comparison of Suzhou Highfine Biotech Co's PB Ratio

For the Drug Manufacturers - Specialty & Generic subindustry, Suzhou Highfine Biotech Co's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Suzhou Highfine Biotech Co's PB Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Suzhou Highfine Biotech Co's PB Ratio distribution charts can be found below:

* The bar in red indicates where Suzhou Highfine Biotech Co's PB Ratio falls into.



Suzhou Highfine Biotech Co PB Ratio Calculation

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.

Suzhou Highfine Biotech Co's PB Ratio for today is calculated as follows:

PB Ratio=Share Price/Book Value per Share (Q: Jun. 2024)
=37.10/20.558
=1.80

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.


Suzhou Highfine Biotech Co  (SZSE:301393) PB Ratio Explanation

Unlike valuation ratios relative to the earning power such as PE Ratio, PE Ratio without NRI, PS Ratio, Price-to-Operating-Cash-Flow , or Price-to-Free-Cash-Flow, the PB Ratio measures the valuation of the stock relative to the underlying asset of the company.

The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.


Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.


Suzhou Highfine Biotech Co PB Ratio Related Terms

Thank you for viewing the detailed overview of Suzhou Highfine Biotech Co's PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Suzhou Highfine Biotech Co Business Description

Traded in Other Exchanges
N/A
Address
No. 32 Hongxi Road, F-12 Standard Factory Building, High-tech Zone, Jiangsu Province, Suzhou, CHN, 215151
Suzhou Highfine Biotech Co Ltd is a high-tech enterprise that provides characteristic raw materials for global pharmaceutical research and development and raw material drug production companies. The products are mainly used in the fields of peptide, nucleotide and pharmaceutical synthesis. The product range covers peptide synthesis reagents for characteristic amide bond formation, molecular building blocks, protein reagents, liposome and lipid nanoparticle pharmaceutical reagents, ionic liquids , PROTAC reagents and nucleotide reagents and other types.
Executives
Dong Sheng Jun Directors, executives
Lu Xue Gen Directors, executives
Lv Min Jie Directors, executives
Xu Jie Directors, executives

Suzhou Highfine Biotech Co Headlines

No Headlines